These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 1434892
1. National survey of use of mesna for the prevention of cyclophosphamide-induced hemorrhagic cystitis in recipients of bone marrow transplants. Nicolau DP, Hogan KR. Mayo Clin Proc; 1992 Jun; 67(6):611-2. PubMed ID: 1434892 [No Abstract] [Full Text] [Related]
2. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis. Luce JK, Simons JA. Med Pediatr Oncol; 1988 Jun; 16(6):372-4. PubMed ID: 3143903 [Abstract] [Full Text] [Related]
3. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. J Clin Oncol; 1991 Nov; 9(11):2016-20. PubMed ID: 1941060 [Abstract] [Full Text] [Related]
4. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy. Andriole GL, Sandlund JT, Miser JS, Arasi V, Linehan M, Magrath IT. J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585 [Abstract] [Full Text] [Related]
5. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study. Hows JM, Mehta A, Ward L, Woods K, Perez R, Gordon MY, Gordon-Smith EC. Br J Cancer; 1984 Dec; 50(6):753-6. PubMed ID: 6437430 [Abstract] [Full Text] [Related]
6. Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation. Jaiswal SR, Singhal P, Thatai A, Bhagwati G, Aiyer HM, Chakrabarti A, Chakrabarti S. Ann Hematol; 2020 Apr; 99(4):839-845. PubMed ID: 32025839 [Abstract] [Full Text] [Related]
7. A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients. Khojasteh NH, Zakerinia M, Ramzi M, Haghshenas M. Transplant Proc; 2000 May; 32(3):596. PubMed ID: 10812128 [No Abstract] [Full Text] [Related]
8. Protective effects of lipoic acid and mesna on cyclophosphamide-induced haemorrhagic cystitis in mice. Song J, Liu L, Li L, Liu J, Song E, Song Y. Cell Biochem Funct; 2014 Mar; 32(2):125-32. PubMed ID: 23650119 [Abstract] [Full Text] [Related]
9. [Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan]. Czownicki Z, Utracka-Hutka B. Nowotwory; 1981 Mar; 30(4):377-83. PubMed ID: 6792599 [No Abstract] [Full Text] [Related]
10. Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data). Hows J, Mehta A, Gordon-Smith EC. Cancer Treat Rev; 1983 Sep; 10 Suppl A():53-6. PubMed ID: 6414696 [No Abstract] [Full Text] [Related]
11. Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation. Link H, Neef V, Niethammer D, Wilms K. Blut; 1981 Nov; 43(5):329-30. PubMed ID: 6799018 [No Abstract] [Full Text] [Related]
12. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. Vose JM, Reed EC, Pippert GC, Anderson JR, Bierman PJ, Kessinger A, Spinolo J, Armitage JO. J Clin Oncol; 1993 Jul; 11(7):1306-10. PubMed ID: 8315426 [Abstract] [Full Text] [Related]
13. [Usefulness of 2-mercaptoethanol sodium sulfonate (Mesnum) in the prevention of hemorrhagic cystitis in patients undergoing bone marrow transplantation]. Grañena A, Gardella S, Marín P, Carreras E, Montserrat E, Rozman C. Sangre (Barc); 1986 Jul; 31(3):307-10. PubMed ID: 3092373 [No Abstract] [Full Text] [Related]
14. Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy. Haselberger MB, Schwinghammer TL. Ann Pharmacother; 1995 Sep; 29(9):918-21. PubMed ID: 8547741 [Abstract] [Full Text] [Related]
15. Experience with mesna in patients receiving allogeneic bone marrow transplants for poor prognostic leukaemia. Blacklock H, Ball L, Knight C, Schey S, Prentice G. Cancer Treat Rev; 1983 Sep; 10 Suppl A():45-52. PubMed ID: 6414695 [No Abstract] [Full Text] [Related]
16. Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients. Ballen KK, Becker P, Levebvre K, Emmons R, Lee K, Levy W, Stewart FM, Quesenberry P, Lowry P. Oncology; 1999 Nov; 57(4):287-92. PubMed ID: 10575313 [Abstract] [Full Text] [Related]
17. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs. Korkmaz A, Oter S, Deveci S, Goksoy C, Bilgic H. J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309 [Abstract] [Full Text] [Related]
18. Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna. Morais MM, Belarmino-Filho JN, Brito GA, Ribeiro RA. Braz J Med Biol Res; 1999 Oct; 32(10):1211-5. PubMed ID: 10510257 [Abstract] [Full Text] [Related]
19. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis. Ehrlich RM, Freedman A, Goldsobel AB, Stiehm ER. J Urol; 1984 May; 131(5):960-2. PubMed ID: 6423841 [Abstract] [Full Text] [Related]